Treatment of hyperbilirubinemia pharmacologic approach SnMP(tin-mesoporphyrin)
- PMID: 11803428
- DOI: 10.1038/sj.jp.7210655
Treatment of hyperbilirubinemia pharmacologic approach SnMP(tin-mesoporphyrin)
Similar articles
-
Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant.J Perinatol. 2003 Sep;23(6):507-8. doi: 10.1038/sj.jp.7210943. J Perinatol. 2003. PMID: 13679941
-
Tin-metalloporphyrins: an answer to neonatal jaundice?Neonatal Netw. 1998 Aug;17(5):11-7; quiz 18-9. Neonatal Netw. 1998. PMID: 9791442 Review.
-
Chemoprevention of severe neonatal hyperbilirubinemia.Semin Perinatol. 2004 Oct;28(5):365-8. doi: 10.1053/j.semperi.2004.09.004. Semin Perinatol. 2004. PMID: 15686268 Review.
-
Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility.J Perinatol. 2012 Nov;32(11):899-900. doi: 10.1038/jp.2012.45. J Perinatol. 2012. PMID: 23128060
-
New approach to prevention of kernicterus.Lancet. 1999 May 29;353(9167):1814-5. doi: 10.1016/s0140-6736(99)90077-6. Lancet. 1999. PMID: 10359401 No abstract available.
Cited by
-
HO-1 overexpression and underexpression: Clinical implications.Arch Biochem Biophys. 2019 Sep 30;673:108073. doi: 10.1016/j.abb.2019.108073. Epub 2019 Aug 16. Arch Biochem Biophys. 2019. PMID: 31425676 Free PMC article. Review.
-
Tin Mesoporphyrin Selectively Reduces Non-Small-Cell Lung Cancer Cell Line A549 Proliferation by Interfering with Heme Oxygenase and Glutathione Systems.Biomolecules. 2021 Jun 21;11(6):917. doi: 10.3390/biom11060917. Biomolecules. 2021. PMID: 34205698 Free PMC article.
-
"Light" on Phototherapy-Complications and Strategies for Shortening Its Duration, A Review of the Literature.Children (Basel). 2023 Oct 17;10(10):1699. doi: 10.3390/children10101699. Children (Basel). 2023. PMID: 37892362 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources